Filter
2463
Filtered Results: 2463
Text search:
drug-resistance
infections
Featured
Recommendations
279
New Publications
654
Language
Document type
No document type
1405
Guidelines
393
Studies & Reports
373
Manuals
102
Strategic & Response Plan
82
Fact sheets
40
Training Material
36
Situation Updates
13
Infographics
10
Brochures
3
Resource Platforms
3
Online Courses
2
Videos
1
Countries / Regions
India
137
South Africa
73
Kenya
71
Western and Central Europe
67
Global
66
Ethiopia
55
Tanzania
43
Africa
42
Uganda
42
Eastern Europe
42
Nepal
41
Nigeria
37
Zambia
35
Liberia
32
Latin America and the Carribbean
31
Malawi
30
Sierra Leone
29
Rwanda
26
Ghana
25
Bangladesh
24
Namibia
24
Myanmar / Burma
24
Philippines
23
Asia
22
South–East Asia Region
22
Cambodia
20
Zimbabwe
18
Lesotho
17
Ukraine
16
Russia
15
Senegal
13
Indonesia
13
Mozambique
12
Cameroon
11
Congo, Democratic Republic of
11
Botswana
10
Albania
8
Burkina Faso
8
West and Central Africa
8
Eswatini/ Swaziland
8
Thailand
7
East and Southern Africa
7
Pakistan
7
Colombia
6
Syria
6
USA
6
Haiti
6
Venezuela
6
Middle East and North Africa
6
Eastern Europe and Central Asia
6
Argentina
6
China
5
Guinea
5
Georgia
5
Tajikistan
4
Benin
4
Germany
4
Western Pacific Region
4
Brazil
4
Sudan
4
North Macedonia
3
Iran
3
Laos
3
Peru
3
Jordan
3
North America
3
Lebanon
3
Vietnam
3
Central African Republic
3
Bhutan
3
South Sudan
3
Iraq
3
Somalia
3
Timor Leste/ East Timor
2
Mexico
2
El Salvador
2
Estonia
2
Afghanistan
2
Morocco
2
Armenia
2
Saudi Arabia
2
Paraguay
2
Gabon
2
Uruguay
2
Tunisia
2
Côte d’Ivoire / Ivory Coast
2
Papua New Guinea
2
Moldova
2
Sri Lanka
2
Yemen
2
Mali
2
Madagascar
2
Switzerland
1
Serbia
1
Turkey
1
Gambia
1
Canada
1
Fiji
1
Congo-Brazzaville
1
Niger
1
Qatar
1
Guinea-Bissau
1
Turkmenistan
1
Denmark
1
Belgium
1
France
1
Maldives
1
Mauritius
1
United Kingdom
1
Spain
1
Bolivia
1
Oman
1
Nicaragua
1
Egypt
1
Greece
1
Honduras
1
Angola
1
Libya
1
Ecuador
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
857
Clinical Guidelines
285
Public Health
106
Women & Child Health
77
Key Resources
64
Capacity Building
34
Pharmacy & Technologies
32
Annual Report MEDBOX
1
Toolboxes
TB
443
HIV
325
AMR
317
NTDs
111
COVID-19
81
Rapid Response
59
Mental Health
56
Pharmacy
54
Caregiver
45
Planetary Health
41
Ebola & Marburg
32
Refugee
27
Global Health Education
27
NCDs
20
Health Financing Toolbox
17
Polio
16
Conflict
13
Cholera
12
Malaria
12
Natural Hazards
7
Disability
7
Zika
4
Specific Hazards
3
Social Ethics
1
Previous advocacy efforts have achieved tangible goals in terms garnering political commitments
to increase financing for TB—as seen at the 2018 UN High-Level Meeting on TB. The challenge
now is to ensure that these commitments are actually met within a global biomedical research
ecosystem that...
The growing understanding of how sequence information can contribute to improved public health is driving global investments in sequencing facilities and programmes. The falling cost and complexity of generating GSD provides opportunities for expanding sequencing capacity; however, challenges to wid...
Third edition.
The main changes within the third edition of the JEE tool include the split of the technical area National legislation, policy, and financing into two technical areas (Legal instruments and Financing); the drop of the technical area previously titled Reporting and the move of indicat...
n light of the potential risk posed by SARS-CoV-2 variants, in January 2021 WHO organized an ad hoc consultation to discuss the development of an R&D agenda in response to existing and emerging SARS-CoV-2 variants.
The key objectives were to identify the critical research questions related to var...
Updated 10 August 2020
This document presents an essential medicines list (EML) to manage patients in intensive care units (ICUs) with suspected or confirmed COVID-19 diagnosis, which includes active ingredients with dosage form and concentration, and are preferably in the WHO Model Lists of Essent...
Accessed on 04.04.2023
The Drugs for Neglected Diseases initiative (DNDi) is an international
non-profit organization that discovers, develops, and delivers safe,
effective, and affordable treatments for the most neglected patients
This Mpox SPRP Global Monitoring & Evaluation (M&E) Framework, also referred to as the Framework, aims to monitor and report on global progress towards these objectives, including information about country-level response efforts and WHO support to Member States. Regular collection and analysis of da...
Laboratory biosafety manual
recommended
4th edition
The WHO Laboratory Biosafety Manual (LBM) has been in broad use at all levels of clinical and public health laboratories, and other biomedical sectors globally, serving as a de facto global standard that presents best practices and sets trends in biosafety.
LBM encouraged countries t...
This helpdesk report seeks to establish what lessons have been learnt from the current and previous Ebola outbreaks. It recommends good practice and makes suggestions based on the evidence for good practice and preparedness to reduce transmission and prevent further risk and exposure in affected cou...
The World Health Organization (WHO) and the global community of countries, partners, donors, technical experts, scientists and field implementation teams continue to work towards the ultimate goal of a world free of the burden of neglected tropical diseases (NTDs).
Vision 2030
Accessed: 17.11.2019
This compendium collates current tools and resources on quality improvement developed by the WHO Service Delivery and Safety Department and provides examples of how the tools and resources have been applied in country settings. The target audience for this document are ministries of health, facility...
The Country Cooperation Strategy is the World Health Organization (WHO)’s reference for country work guiding planning and resource allocation through alignment with national health priorities and harmonization with other development partners. It clarifies roles and functions of WHO in supporting t...
